203 related articles for article (PubMed ID: 37009790)
1. Evogliptin, a DPP-4 inhibitor, prevents diabetic cardiomyopathy by alleviating cardiac lipotoxicity in db/db mice.
Pham TK; Nguyen THT; Yi JM; Kim GS; Yun HR; Kim HK; Won JC
Exp Mol Med; 2023 Apr; 55(4):767-778. PubMed ID: 37009790
[TBL] [Abstract][Full Text] [Related]
2. Blackcurrant Improves Diabetic Cardiovascular Dysfunction by Reducing Inflammatory Cytokines in Type 2 Diabetes Mellitus Mice.
Kim HY; Yoon JJ; Lee HK; Tai AL; Lee YJ; Kim DS; Kang DG; Lee HS
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836432
[TBL] [Abstract][Full Text] [Related]
3. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
[TBL] [Abstract][Full Text] [Related]
4. The Dose-Dependent Organ-Specific Effects of a Dipeptidyl Peptidase-4 Inhibitor on Cardiovascular Complications in a Model of Type 2 Diabetes.
Moon JY; Woo JS; Seo JW; Lee A; Kim DJ; Kim YG; Kim SY; Lee KH; Lim SJ; Cheng XW; Lee SH; Kim W
PLoS One; 2016; 11(3):e0150745. PubMed ID: 26959365
[TBL] [Abstract][Full Text] [Related]
5. Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits.
Zhang X; Zhang Z; Yang Y; Suo Y; Liu R; Qiu J; Zhao Y; Jiang N; Liu C; Tse G; Li G; Liu T
Cardiovasc Diabetol; 2018 Dec; 17(1):160. PubMed ID: 30591063
[TBL] [Abstract][Full Text] [Related]
6. Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes.
Huynh K; Kiriazis H; Du XJ; Love JE; Jandeleit-Dahm KA; Forbes JM; McMullen JR; Ritchie RH
Diabetologia; 2012 May; 55(5):1544-53. PubMed ID: 22374176
[TBL] [Abstract][Full Text] [Related]
7. Empagliflozin Ameliorates Diabetic Cardiomyopathy via Attenuating Oxidative Stress and Improving Mitochondrial Function.
Wang J; Huang X; Liu H; Chen Y; Li P; Liu L; Li J; Ren Y; Huang J; Xiong E; Tian Z; Dai X
Oxid Med Cell Longev; 2022; 2022():1122494. PubMed ID: 35585884
[TBL] [Abstract][Full Text] [Related]
8. FNDC5/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin αV/β5-AKT signaling and reduction of oxidative/nitrosative stress.
Lin C; Guo Y; Xia Y; Li C; Xu X; Qi T; Zhang F; Fan M; Hu G; Zhao H; Zhao H; Liu R; Gao E; Yan W; Tao L
J Mol Cell Cardiol; 2021 Nov; 160():27-41. PubMed ID: 34224725
[TBL] [Abstract][Full Text] [Related]
9. SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor.
Ye Y; Bajaj M; Yang HC; Perez-Polo JR; Birnbaum Y
Cardiovasc Drugs Ther; 2017 Apr; 31(2):119-132. PubMed ID: 28447181
[TBL] [Abstract][Full Text] [Related]
10. Combined treatment of dipeptidyl peptidase-4 inhibitor and exercise training improves lipid profile in KK/Ta mice.
Tanimura Y; Aoi W; Mizushima K; Higashimura Y; Naito Y
Exp Physiol; 2019 Jul; 104(7):1051-1060. PubMed ID: 31020720
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin 1-7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db/db mice by reducing lipotoxicity and inflammation.
Mori J; Patel VB; Abo Alrob O; Basu R; Altamimi T; Desaulniers J; Wagg CS; Kassiri Z; Lopaschuk GD; Oudit GY
Circ Heart Fail; 2014 Mar; 7(2):327-39. PubMed ID: 24389129
[TBL] [Abstract][Full Text] [Related]
12. Effects of DPP-4 inhibition on cardiac metabolism and function in mice.
Lenski M; Kazakov A; Marx N; Böhm M; Laufs U
J Mol Cell Cardiol; 2011 Dec; 51(6):906-18. PubMed ID: 21871459
[TBL] [Abstract][Full Text] [Related]
13. Mst1 knockdown alleviates cardiac lipotoxicity and inhibits the development of diabetic cardiomyopathy in db/db mice.
Xiong Z; Li Y; Zhao Z; Zhang Y; Man W; Lin J; Dong Y; Liu L; Wang B; Wang H; Guo B; Li C; Li F; Wang H; Sun D
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165806. PubMed ID: 32320827
[TBL] [Abstract][Full Text] [Related]
14. Shengmai San Alleviates Diabetic Cardiomyopathy Through Improvement of Mitochondrial Lipid Metabolic Disorder.
Tian J; Tang W; Xu M; Zhang C; Zhao P; Cao T; Shan X; Lu R; Guo W
Cell Physiol Biochem; 2018; 50(5):1726-1739. PubMed ID: 30384366
[TBL] [Abstract][Full Text] [Related]
15. Recombinant Human Growth Hormone Inhibits Lipotoxicity, Oxidative Stress, and Apoptosis in a Mouse Model of Diabetic Cardiomyopathy.
Pei Z; Wang X; Yang C; Dong M; Wang F
Oxid Med Cell Longev; 2021; 2021():3899356. PubMed ID: 34925693
[TBL] [Abstract][Full Text] [Related]
16. Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice.
Xue M; Li T; Wang Y; Chang Y; Cheng Y; Lu Y; Liu X; Xu L; Li X; Yu X; Sun B; Chen L
Clin Sci (Lond); 2019 Aug; 133(15):1705-1720. PubMed ID: 31337673
[TBL] [Abstract][Full Text] [Related]
17. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876
[TBL] [Abstract][Full Text] [Related]
18. Peroxiredomin-4 ameliorates lipotoxicity-induced oxidative stress and apoptosis in diabetic cardiomyopathy.
Zhang B; Li X; Liu G; Zhang C; Zhang X; Shen Q; Sun G; Sun X
Biomed Pharmacother; 2021 Sep; 141():111780. PubMed ID: 34130124
[TBL] [Abstract][Full Text] [Related]
19. Zinc Prevents the Development of Diabetic Cardiomyopathy in db/db Mice.
Wang S; Wang B; Wang Y; Tong Q; Liu Q; Sun J; Zheng Y; Cai L
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272348
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy.
Sharkovska Y; Reichetzeder C; Alter M; Tsuprykov O; Bachmann S; Secher T; Klein T; Hocher B
J Hypertens; 2014 Nov; 32(11):2211-23; discussion 2223. PubMed ID: 25215436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]